(Q46786980)

25 December 2017

title

Can dexrazoxane reduce myocardial injury in anthracycline-treated children with acute lymphoblastic leukemia? (English)

1 reference

25 December 2017

author name string

Jeffrey H Silber

series ordinal

1

1 reference

25 December 2017

publication date

1 November 2004

1 reference

25 December 2017

Nature Clinical Practice Oncology

published in

1 reference

25 December 2017

volume

1

1 reference

25 December 2017

issue

1

1 reference

25 December 2017

page(s)

16-17

1 reference

25 December 2017

The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0023

Enalapril to prevent cardiac function decline in long-term survivors of pediatric cancer exposed to anthracyclines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0023

Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0023

inferred from DOI database lookup

7 January 2021

based on heuristic

Marginal analysis applied to the dose-response curve

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0023

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NCPONC0023

1 reference

25 December 2017

1 reference

25 December 2017